Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

AMGN - AMGEN INC


IEX Last Trade
261.22
-0.290   -0.111%

Share volume: 66,235
Last Updated: Fri 10 Jan 2025 08:29:53 PM CET
Research and Development in Biotechnology (except Nanobiotechnology): -0.49%

PREVIOUS CLOSE
CHG
CHG%

$261.51
-0.29
-0.11%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2023-03-31 2023-06-30 2023-09-30 2023-12-31 2024-03-31 2024-06-30 2024-09-30
Fiscal Quarter Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024
Report Date 2024-05-02 2023-08-03 2023-10-31 2024-10-30 2024-05-02 2024-08-06 2024-10-30
Total revenue 6.105 B 6.986 B 6.903 B 8.196 B 7.447 B 8.388 B 8.503 B
Cost of revenue 1.720 B 1.813 B 1.806 B 3.112 B 3.200 B 3.236 B 3.310 B
Gross profit 4.385 B 5.173 B 5.097 B 5.084 B 4.247 B 5.152 B 5.193 B
    17.97% -1.47% -0.26% -16.46% 21.31% 0.80%  
Operating expenses 2.316 B 2.407 B 2.432 B 4.687 B 3.151 B 3.232 B 3.075 B
Selling general and admin 1.258 B 1.294 B 1.353 B 3.153 B 1.808 B 1.785 B 1.625 B
Research and development 1.058 B 1.113 B 1.079 B 1.534 B 1.343 B 1.447 B 1.450 B
Total expenses 2.464 B 2.489 B 3.076 B 3.813 B 3.256 B 3.243 B 3.146 B
    1.01% 23.58% 23.96% -14.61% -0.40% -2.99%  
Operating income 1.921 B 2.684 B 2.021 B 1.271 B 991.000 M 1.909 B 2.047 B
Ebit 3.985 B 2.366 B 2.706 B 1.673 B 756.000 M 1.602 B 3.877 B
Pretax income 3.442 B 1.614 B 1.947 B 852.000 M -68.000 M 794.000 M 3.101 B
    -53.11% 20.63% -56.24% -107.98% -1,267.65% 290.55%  
Income tax 601.000 M 235.000 M 217.000 M 85.000 M 45.000 M 48.000 M 271.000 M
Net income basic 0.000 0.000 0.000 0.000 0.000 0.000 0.000
                 
Net income 2.841 B 1.379 B 1.730 B 767.000 M -113.000 M 746.000 M 2.830 B
    -51.46% 25.45% -55.66% -114.73% 760.18% 279.36%